Sign in

CIK 0001819790 · Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
814717861
Phone
(949) 409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
  1. 4 Option exercise Chief Commercial Officer acquired 26,482 shares (option exercise)
  2. 4 Option exercise See Remarks acquired 13,042 shares (option exercise)
  3. 4 Option exercise President/CEO and Board Chair acquired 66,274 shares (option exercise)
  4. 4 Option exercise Chief Medical Officer acquired 2,511 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale Chief Operating Officer sold 8,366 shares at $76.67 ($641,421)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Option exercise Director acquired 2,233 shares (option exercise)
  16. 4 Planned sale Chief Human Resources Officer sold 15,565 shares at an average $80.67 ($1,255,684)
  17. 4 Planned sale President/CEO and Board Chair sold 6,000 shares at an average $82.51 ($495,089)
  18. 4 Gift Chief Operating Officer gave 950 shares (gift)
  19. 4 Planned sale Chief Human Resources Officer sold 7,397 shares at $80.10 ($592,500)
  20. 4 Planned sale Director sold 22,946 shares at an average $81.26 ($1,864,678)

Page 3 of 17 · 330 filings